News

Explore the powerful memoirs of Kay Redfield Jamison, offering profound insights into living with bipolar disorder and the complexities of love.

Exploring the prevalence and implications of psychotropic polypharmacy in patients taking clozapine with treatment-resistant schizophrenia.

Neuroplasticity enables the brain to adapt and recover after injury, emphasizing the importance of multidisciplinary rehabilitation for effective healing.

Neuphoria Therapeutics announces successful enrollment in a pivotal trial for BNC-210, a promising treatment for social anxiety disorder.

Explore the intersection of technology and memory as holograms of genocide survivors inspire hope and healing in today's world.

Read the exclusive August Special Report on issues in diversity!

Explore the complex interplay of genetics, environment, concussion, substance abuse, and inflammation in severe mental illnesses, revealing critical insights for prevention and treatment.

Achieve Life Sciences gains FDA acceptance for cytisinicline, a promising new drug for smoking cessation, showing significant abstinence rates in trials.

A new guideline from the APA enhance the prevention and treatment of delirium, aiming to improve patient care and outcomes in clinical settings.

Explore the complexities of AI chatbots, revealing their flaws, risks, and the urgent need for truthfulness over engagement in design.

Today marks 4 years of "Psychiatric Views on the Daily News"! Celebrate with H. Steven Moffic, MD.

Submit to our September theme: Diagnosis Dilemmas!

Through poetry, explore the inspiring journey of Dr Benjamin Griffeth, a retired Navy veteran, as his colleague Dr Frank Clark reflects on his impactful legacy.

Psychiatrists navigate the complexities of mental health care, balancing evidence-based practices with patient-centered approaches amidst social media scrutiny.

The FDA has approved the Leqembi subcutaneous autoinjector for at-home Alzheimer disease treatment.

Check out the pipeline updates from August!

A new mobile app has been found to reduce suicidal behavior post hospitalization in patients at high suicide risk.

Explore Joe Pierre, MD's insightful analysis of why we believe falsehoods, blending psychology and cognitive science to address misinformation's impact on society.

Explore the psychological interplay of love and aggression in wartime, as Freud's theories resonate with today's conflicts and relationships.

Trauma can span generations. Let's help break the cycle with these 10 steps.

Care partners for patients with schizophrenia can greatly benefit from psychoeducation provided by clinicians.

Obesity is more than a weight issue--it can be reclassified as an embodied disorder. This reflection explores how shame, bodily self-awareness, and early developmental disruptions shape the lived experience of being overweight

NRX-100, a preservative-free ketamine, is granted expanded access for treatment of suicidal ideation in depression, offering new hope for patients.

Black youth, particularly boys, face mischaracterization and punishment in schools.

A farewell to Max Fink, MD, who passed this June. He was a pioneer in the field of electroconvulsive therapy.

BioXcel Therapeutics reveals promising phase 3 results from the SERENITY trial, paving the way for potential at-home treatment of agitation in bipolar disorder and schizophrenia.

Dive into the forms of assessment for cognitive dysfunction in relation to the diagnosis and treatment of schizophrenia.